Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR).

When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.

HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[Activity Report] Submission of recommendations to Public Comment on the “Draft Order of the Pandemic Influenza and New Infection Diseases Preparedness and Response Council”
2021-03-25

[Activity Report] Submission of recommendations to Public Comment on the “Draft Or ...>>

[Recommendations] Creating Pull Incentives for Antimicrobials (March 24, 2021)
2021-03-24

[Recommendations] Creating Pull Incentives for Antimicrobials (March 24, 2021)>>

[Event Report] The Fifth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (March 12, 2021)
2021-03-23

[Event Report] The Fifth Meeting of the AMR Consortium of the Nikkei FT Communicable Dis ...>>

[New Report] The Threat of AMR to Japan’s Super-Aging Society: Implications on Health Care, Public Policy, and Economic Well-Being (February 22, 2021)
2021-02-21

[New Report] The Threat of AMR to Japan’s Super-Aging Society: Implications on Health C ...>>

[Event Report] The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 14, 2020)
2021-02-19

[Event Report] The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Di ...>>

[Event Report] Stabilizing the Supply of Antimicrobials: An AMR Alliance Japan Forum (January 15, 2021)
2021-02-18

[Event Report] Stabilizing the Supply of Antimicrobials: An AMR Alliance Japan Forum (Ja ...>>

[Press Release] Don’t Ignore the ‘Silent Pandemic’ of AMR in Revisions to the Infectious Diseases Control Law and Other Laws (January 26, 2021)
2021-02-05

[Press Release] Don’t Ignore the ‘Silent Pandemic’ of AMR in Revisions to the Infectious ...>>

[Event Report] The 46th Special Breakfast Meeting – Looking Back on 1,124 Days as Chief Medical and Global Health Officer – The Past and Future of the Healthcare System (December 11, 2020)
2021-02-03

[Event Report] The 46th Special Breakfast Meeting – Looking Back on 1,124 Days as Chief ...>>

[Event Report] The 89th HGPI Seminar – Treating the “Untreatable” – How the UK is Incentivizing New Antimicrobial Development to Fight the AMR Crisis (October 19, 2020)
2020-12-28

[Event Report] The 89th HGPI Seminar – Treating the “Untreatable” – How the UK is Incent ...>>

[Activity Report] The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (November 7, 2020)
2020-12-01

[Activity Report] The 7th NIKKEI FT Communicable Diseases Conference – The AMR Con ...>>

[Activity Report] New Policy Briefs on the Situation of AMR in Japan and Abroad (November 20, 2020)
2020-11-20

[Activity Report] New Policy Briefs on the Situation of AMR in Japan and Abroad (Novembe ...>>

[Event Report] The Third Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (October 8, 2020)
2020-11-07

[Event Report] The Third Meeting of Working Group 2 Under the Sub-committee on AMR of th ...>>

PageTop